Yilong Zhu Selected Research

Annexin A5

1/2020

Anti-tumor Synergistic Effect of a Dual Cancer-Specific Recombinant Adenovirus and Paclitaxel on Breast Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yilong Zhu Research Topics

Disease

16	Neoplasms (Cancer) 07/2023 - 11/2018
5	Infections 10/2023 - 01/2017
5	Liver Neoplasms (Liver Cancer) 07/2023 - 01/2020
4	Hepatocellular Carcinoma (Hepatoma) 02/2024 - 01/2020
4	Lung Neoplasms (Lung Cancer) 10/2022 - 11/2018
4	Breast Neoplasms (Breast Cancer) 10/2022 - 01/2020
3	COVID-19 01/2023 - 01/2021
1	Ulcerative Colitis 11/2023
1	Dysbiosis 11/2023
1	Colitis 11/2023
1	Mpox (monkeypox) 10/2023
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2023
1	Hepatitis B 01/2023
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 05/2022
1	Adenocarcinoma of Lung 01/2022
1	Human Influenza (Influenza) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Conversion Disorder (Astasia Abasia) 11/2021
1	Melanoma (Melanoma, Malignant) 01/2021
1	Viral Pneumonia 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2021
1	Severe Acute Respiratory Syndrome 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 11/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2020
1	Dermatitis 02/2019
1	Inflammation (Inflammations) 02/2019
1	Poxviridae Infections 01/2018
1	Fowlpox 06/2017
1	Body Weight (Weight, Body) 01/2017
1	Convalescence 01/2017

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2018
6	Gentian Violet (Violet, Crystal)FDA Link 10/2022 - 01/2020
3	Sincalide FDA Link 10/2022 - 01/2020
3	EnzymesIBA 10/2022 - 01/2021
3	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2018
2	CytokinesIBA 11/2023 - 01/2017
2	bafilomycin A1IBA 01/2023 - 01/2021
2	Hydroxyl RadicalIBA 01/2023 - 01/2022
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2022 - 01/2021
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 01/2020
2	Gemcitabine FDA Link 01/2022 - 01/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 01/2020
2	5,5',6,6'- tetrachloro- 1,1',3,3'- tetraethylbenzimidazolocarbocyanineIBA 11/2020 - 01/2020
1	peimisineIBA 11/2023
1	Membrane Proteins (Integral Membrane Proteins)IBA 10/2023
1	Surface Antigens (Surface Antigen)IBA 10/2023
1	Immunoglobulin G (IgG)IBA 10/2023
1	mRNA VaccinesIBA 10/2023
1	vironIBA 10/2023
1	neobavaisoflavoneIBA 07/2023
1	AntioxidantsIBA 07/2023
1	ferric ferrocyanide (Prussian blue)FDA Link 01/2023
1	EpitopesIBA 01/2023
1	Beclin-1IBA 01/2023
1	ferrostatin-1IBA 01/2023
1	Virus-Like Particle VaccinesIBA 01/2023
1	esculetinIBA 01/2023
1	Pyruvate KinaseIBA 10/2022
1	Tamoxifen FDA LinkGeneric 10/2022
1	Etoposide (VP 16)FDA LinkGeneric 05/2022
1	Therapeutic UsesIBA 05/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	AtractylosideIBA 01/2022
1	Caspase 3 (Caspase-3)IBA 01/2022
1	Apoptosis Regulatory ProteinsIBA 01/2022
1	caryophyllene oxideIBA 01/2022
1	IronIBA 01/2022
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2022
1	Malondialdehyde (Propanedial)IBA 01/2022
1	myricetinIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 12/2021
1	LuciferasesIBA 01/2021
1	Chloroquine (Aralen)FDA LinkGeneric 01/2021
1	SuspensionsIBA 01/2021
1	Mitochondrial Permeability Transition PoreIBA 01/2021
1	antibiotic G 418IBA 01/2021
1	FITC-annexin A5IBA 11/2020
1	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2020
1	Annexin A5IBA 01/2020
1	Circular DNAIBA 02/2019
1	Cisplatin (Platino)FDA LinkGeneric 11/2018
1	InterferonsIBA 01/2018
1	VaccinesIBA 06/2017
1	Interferon-gamma (Interferon, gamma)IBA 01/2017
1	Secretory Immunoglobulin A (SIgA)IBA 01/2017
1	Interleukin-4 (Interleukin 4)IBA 01/2017

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 02/2024 - 01/2020
3	Oncolytic Virotherapy 05/2022 - 01/2020
3	Therapeutics 01/2022 - 01/2020
1	Electrodes (Electrode) 11/2021
1	Aftercare (After-Treatment) 11/2018
1	Oral Administration 01/2017